Feedback / Questions
amuvatinib (MP470) - Otsuka
Stifel Nicolaus Healthcare Conference
(Astex)
-
Sep 7, 2012 -
Anticipated data from P2 proof-of-concept ESCAPE trial in SCLC in Q4 2012
Anticipated P2 data
•
Oncology
http://www.larvolonline.com/tlg/ccdb/AstexTherapeuticsStifelNicolausHealthcareConferenceSep062012.pdf
Sep 7, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR 6)